TAK logo

TAK Other Income/Expenses (Net)

Latest reported-¥38.70B JPY
TAK Quarterly Other Income/Expenses (Net) · JPY (-¥143.47B → -¥38.70B)
High-resolution chart · PNG

TAK other income/expenses (net) history

Quarterly · JPY. Dates are reporting period ends; fiscal years can differ from calendar years.

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) Other Income/Expenses (Net) — Quarterly (JPY)
Period endingOther Income/Expenses (Net) (JPY)
-38,699,000,000
-100,984,733,000
-57,782,633,000
-40,821,000,000
-33,936,000,000
-32,400,000,000
-40,535,000,000
-64,875,000,000
-29,725,000,000
-37,453,000,000
-43,654,000,000
-46,638,000,000
-33,120,000,000
-40,647,000,000
-39,837,000,000
-39,020,000,000
5,455,000,000
-52,428,000,000
-44,291,000,000
-35,980,000,000
-25,574,000,000
-19,662,000,000
-33,345,000,000
-53,033,000,000
-36,994,000,000
-54,626,000,000
-28,669,000,000
-19,393,000,000
249,000,000
-34,032,000,000
-64,865,000,000
-6,169,000,000
-5,007,000,000
9,812,000,000
-33,035,000,000
-4,628,000,000
3,267,000,000
-3,910,000,000
-1,553,000,000
-3,801,000,000
-3,256,000,000
2,584,000,000
-4,463,000,000
-7,572,000,000
-838,000,000
-4,697,000,000
-7,926,000,000
140,000,000
-3,700,000,000
-12,511,000,000
12,000,000,000
11,686,000,000
-7,038,000,000
-8,089,000,000
-12,253,000,000
-145,508,000,000
-140,371,000,000
337,586,000,000
-135,750,000,000
-113,017,000,000
-101,368,000,000
324,443,000,000
-106,183,000,000
-98,125,000,000
-115,650,000,000
330,397,000,000
-110,192,000,000
-119,407,000,000
-105,179,000,000
368,407,000,000
-117,231,000,000
-143,469,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.